Search

everythinglearnresearchcommunity

for

Search:↓

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Healthcare workers with COVID-19 reported more long-term symptoms, and physical activity may help reduce some of these symptoms.

Long COVID symptoms are linked to immune issues, poor blood flow, and lung problems.

Nociplastic pain is a complex, heritable trait with genetic links to chronic and neuropathic pain.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Experts recommend a team-based approach to treat patients with long-lasting COVID-19 symptoms and emphasize the need for ongoing research.

Interest in long-COVID symptoms in Japan increased with COVID-19 case peaks, especially for hair loss, cough, smell/taste issues, and headache.

Kampo medicine can help treat general fatigue from long COVID.

Certain proteins might predict surgical success in trigeminal neuralgia treatment.

Long COVID sufferers face significant challenges that need more public awareness and support.

Long COVID affects many survivors with ongoing symptoms, needing more research and care.

Tailored neurorehabilitation programs improve life quality for post-COVID-19 patients.

Abusing steroids can damage your heart, muscles, reproductive system, liver, skin, and brain, and may increase the risk of Alzheimer's disease.

Many patients with Giant Cell Arteritis did not follow their steroid treatment plans properly.

The patient had a severe allergic reaction to gold treatment.

The document concludes that using gadolinium-based contrast agents during MRI can be linked to Nephrogenic Systemic Fibrosis in patients with severe kidney disease.

A Japanese man with rare skin conditions improved with hydroxychloroquine treatment.

DCPA is a chronic leg infection often related to Staphylococcus aureus, affecting mostly young men in India.

Trichodynia found in 29% of TE or AGA patients, linked to psychological conditions.

"20-nail dystrophy" can have multiple causes.

AMT® is effective and safe for early-stage knee osteoarthritis.

Rituximab improved her dermatomyositis better than usual treatments.

Targeting adipocyte-to-mesenchymal transition could help treat fibrosis.

Topical anaesthesia reduces injection pain better than a vibrating device.

Managing recurrent painless thyroiditis is challenging and should be personalized based on episode frequency, severity, symptoms, and patient preferences.

Vibration anesthesia effectively and safely reduces pain during botulinum toxin injections.

A patient got Herpes zoster after a knee injection, possibly due to the injection's trauma, but more evidence is needed.

Combining platelet-rich plasma injections and gel may effectively treat morphea, improving skin elasticity and reducing pain.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

The conclusion is that "trichoknesis" should be recognized as a separate condition from trichodynia, characterized by itching instead of pain.